SCHEMBL17876159

SCHEMBL17876159

CC1(C)Oc2cc(-c3cc(-c4ccccc4)cc(-c4ccccc4)c3)ccc2-c2cc(-c3ccc4c(c3)oc3ccccc34)ccc2O1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.38
MMP13 P45452 1/20 0.38
AHR P35869 2/20 0.35
PLA2G2A P14555 3/20 0.35
PLA2G4A P47712 3/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
MAPT P10636 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
PGR P06401 2/20 0.34
HCRTR1 O43613 1/20 0.34
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
PLA2G10 O15496 1/20 0.33
ATM Q13315 1/20 0.33
KIF11 P52732 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
PTGER4 P35408 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876139 1.00 MMP12 (0.38) MMP12MMP13AHRPLA2G2APLA2G4A
SCHEMBL17876200 0.95 MMP12 (0.40) MMP12MMP13AHRPLA2G2APLA2G4A
SCHEMBL17876134 0.94 AHR (0.40) MMP12MMP13AHRMEN1KMT2A
SCHEMBL17876158 0.93 PLA2G2A (0.40) MMP12MMP13AHRPLA2G2APLA2G4A
SCHEMBL17876141 0.93 PLA2G2A (0.40) MMP12MMP13AHRPLA2G2APLA2G4A
SCHEMBL17876140 0.90 PGR (0.38) MMP12MMP13AHRPLA2G2APLA2G4A
SCHEMBL17876133 0.90 HCRTR1 (0.33) MMP12MMP13AHRMEN1KMT2A
SCHEMBL17876172 0.90 HCRTR1 (0.33) MMP12MMP13AHRMEN1KMT2A
SCHEMBL17876148 0.89 PLA2G2A (0.35) PLA2G2APLA2G4AMEN1KMT2AMAPT
SCHEMBL17876170 0.89 PLA2G2A (0.35) PLA2G2APLA2G4AMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 MMP12 4056/4885MMP13 3950/4885AHR 1877/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 MMP12 4056/4885MMP13 3950/4885AHR 1877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.